Trial Profile
The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Atenolol (Primary) ; Losartan (Primary) ; Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Daiichi Sankyo Company
- 14 Aug 2017 New trial record